"DONOVIT-VS" AND ITS ROLE IN COMPLEX THERAPY OF ONCOLOGIC DISEASES

V.V. Sobetskij, M.P. Boichik, G.N. Aksenov, V.V. Tsvetkova, A.P. Butrim

General reactions of radiotherapy (headaches, nausea, dizziness, changes of blood accounts) were absent in patients, who were administered "Donovit-VS" together with radiotherapy. In the control group of patients, identical according to sex and age, general reactions of radiotherapy were in 24% of patients.

There was notified the increase of non-relapse disease in the main group of patients, the improvement of the quality of life (the patients were under observation during 2–3 years).

The reduction of the speed of tumour growth was no less than 77% and metastatic process — 93%.

article